To further examine whether MAL2 expression is potentially tumor suppressive, we assayed common oncogenic properties of three hepatic-derived cells: polarized, hepatic WIF-B cells, nonpolarized, HCC-derived Hep3B cells and nonpolarized, hepatoma-derived Clone 9 cells. Here, MAL2 is linked to hepatocellular carcinoma.